517 related articles for article (PubMed ID: 15156445)
21. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients.
Gentile JH; Sparo MD; Mercapide ME; Luna CM
Medicina (B Aires); 2003; 63(1):9-14. PubMed ID: 12673954
[TBL] [Abstract][Full Text] [Related]
22. Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.
Martínez E; Miró JM; Almirante B; Aguado JM; Fernandez-Viladrich P; Fernandez-Guerrero ML; Villanueva JL; Dronda F; Moreno-Torrico A; Montejo M; Llinares P; Gatell JM;
Clin Infect Dis; 2002 Jul; 35(2):130-9. PubMed ID: 12087518
[TBL] [Abstract][Full Text] [Related]
23. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
Peterson LR
Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
[TBL] [Abstract][Full Text] [Related]
25. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.
Yu VL; Chiou CC; Feldman C; Ortqvist A; Rello J; Morris AJ; Baddour LM; Luna CM; Snydman DR; Ip M; Ko WC; Chedid MB; Andremont A; Klugman KP;
Clin Infect Dis; 2003 Jul; 37(2):230-7. PubMed ID: 12856216
[TBL] [Abstract][Full Text] [Related]
26. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
27. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
28. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae.
Ewig S; Ruiz M; Torres A; Marco F; Martinez JA; Sanchez M; Mensa J
Am J Respir Crit Care Med; 1999 Jun; 159(6):1835-42. PubMed ID: 10351928
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J
Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiological features of antibiotic resistance in Streptococcus pneumoniae strains isolated from patients with pneumococcal pneumonias].
Martynova AV
Probl Tuberk Bolezn Legk; 2007; (12):47-9. PubMed ID: 18326216
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
32. [Community acquired pneumococcal pneumonia in hospitalized adult patients].
Díaz A; Torres C; Flores LJ; García P; Saldías F
Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.
Castanheira M; Gales AC; Mendes RE; Jones RN; Sader HS
Clin Microbiol Infect; 2004 Jul; 10(7):645-51. PubMed ID: 15214878
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
35. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).
Draghi DC; Jones ME; Sahm DF; Tillotson GS
Int J Antimicrob Agents; 2006 Dec; 28(6):525-31. PubMed ID: 17101260
[TBL] [Abstract][Full Text] [Related]
36. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
38. Treatment of penicillin-resistant pneumococcus with penicillin: a case report.
Spencer J; Gonzalez L; Miller RP; Myers ML
J Fam Pract; 1997 May; 44(5):499-503. PubMed ID: 9152269
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
Cantón R; Unal S; Farrell DJ
Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
